Hemin

N/A

Report date: 2024/04/18 20:00:32
NME

Base Information

Drug NameHemin
Drug Alias Name血晶素氯化血红素氯高铁血红素氯化高铁血红素
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeme oxygenase 1 activatorsHeme oxygenase 2 activators
TargetsHeme oxygenase 2Heme oxygenase 1
Therapy Area/IndicationsDiabetic GastroparesisMyelodysplastic SyndromesPorphyria, Variegate +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRush University Medical CenterUniversity Of Texas Medical BranchMayo Clinic
Active IndicationsN/A
Inactive IndicationsDiabetic GastroparesisMyelodysplastic SyndromesPorphyria, Variegate +[5] 

Other Information

ATC CodeB06AB01
Related LinksWikipediaDrugBankKEGG